Renal Cell Carcinoma Clinical Trials
Renal Cell Carcinoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for renal Cell Carcinoma. Corterve aggregates actively recruiting Renal Cell Carcinoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Renal Cell Carcinoma studies
- Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE TrialNCT04510597PHASE3SWOG Cancer Research NetworkMetastatic Clear Cell Renal Cell CarcinomaBirmingham, Alabama
- Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)NCT06770855NAAbramson Cancer Center at Penn MedicineRenal Cell CarcinomaPhiladelphia, Pennsylvania
- Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell CarcinomaNCT05155033PHASE2National Cancer Institute (NCI)Metastatic MelanomaBethesda, Maryland
- Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT TrialNCT07516366PHASE2National Cancer Institute (NCI)Clear Cell Renal Cell CarcinomaNew Haven, Connecticut
- Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell CarcinomaNCT06053658PHASE2M.D. Anderson Cancer CenterRenal Cell CarcinomaIrvine, California
- Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell CancerNCT07227415PHASE1, PHASE2PfizerCarcinoma, Renal CellPhoenix, Arizona
- A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsNCT07115043PHASE1, PHASE2AstraZenecaMelanomaGrand Rapids, Michigan
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsNCT03866382PHASE2National Cancer Institute (NCI)Bladder AdenocarcinomaBirmingham, Alabama
- Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell CarcinomaNCT07300241PHASE1Neomorph, IncClear Cell Renal Cell CarcinomaDuarte, California
- A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid TumorsNCT05536141PHASE1Arcus Biosciences, Inc.Clear Cell Renal Cell CarcinomaBirmingham, Alabama
- Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramNCT06265285PHASE2Mayo ClinicAdvanced Esophageal Squamous Cell CarcinomaJacksonville, Florida
- A Phase 1 Study of the Safety and Tolerability of CTX-10726NCT07419841PHASE1Compass TherapeuticsGastroesophageal Cancer (GC)Phoenix, Arizona
Renal Cell Carcinoma trials by state
Renal Cell Carcinoma trials by metro
Frequently asked questions
- How do I find recruiting Renal Cell Carcinoma clinical trials?
- Browse the actively recruiting Renal Cell Carcinoma studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Renal Cell Carcinoma clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Renal Cell Carcinoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.